We are live on ! Find out more
AUXL

AUXILIUM PHARAMCEUTICALS INC
AUXL

Delisted

AUXL was delisted on the 29th of January, 2015.

Back to rankings

158 hedge funds and large institutions have $2.19B invested in AUXILIUM PHARAMCEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 37 increasing their positions, 53 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $86.6M | Put options by funds: $38.9M

25% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 40

11% more capital invested

Capital invested by funds: $1.97B → $2.19B (+$221M)

5% more funds holding

Funds holding: 150 → 158 (+8)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

30% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 53

Holders
158
Holders Change
+8
Holders Change %
+5.33%
% of All Funds
4.21%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.21%
New
50
Increased
37
Reduced
53
Closed
40
Calls
$86.6M
Puts
$38.9M
Net Calls
+$47.6M
Net Calls Change
-$40.2M

Top Buyers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
+$121M
2
FCM
Farallon Capital Management
California
+$80.1M
3
AQR Capital Management
AQR Capital Management
Connecticut
+$79M
4
OAM
Oxford Asset Management
United Kingdom
+$68.6M
5
MP
Manikay Partners
New York
+$62M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$190M
2
PC
Paulson & Co
New York
-$119M
3
JCI
Jet Capital Investors
New York
-$62.7M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$62.1M
5
CCM
Consonance Capital Management
New York
-$44.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
CPM
176
Chesapeake Partners Management
Maryland
– -$3.73M -125,000 Closed
WA
177
Whitebox Advisors
Minnesota
– -$3.7M -124,099 Closed
LCS
178
Levin Capital Strategies
New York
– -$3.43M -115,038 Closed
SO
179
STRS Ohio
Ohio
– -$3.28M -110,000 Closed
RCAMU
180
Rothschild & Co Asset Management US
Connecticut
– -$3.21M -107,406 Closed
MCM
181
Moore Capital Management
New York
– -$2.98M -100,000 Closed
JGC
182
J. Goldman & Co
New York
– -$2.62M -87,860 Closed
SGA
183
Sector Gamma AS
Norway
– -$2.56M -85,920 Closed
Nomura Holdings
184
Nomura Holdings
Japan
– -$2.02M -67,643 Closed
PL
185
Parkwood LLC
Ohio
– -$896K -30,000 Closed
FM
186
Forward Management
California
– -$746K -25,000 Closed
MOACM
187
Mutual of America Capital Management
New York
– -$746K -25,000 Closed
American Century Companies
188
American Century Companies
Missouri
– -$701K -23,497 Closed
GL
189
GLG LLC
New York
– -$626K -20,979 Closed
Bank of Montreal
190
Bank of Montreal
Ontario, Canada
– -$351K -11,769 Closed
Neuberger Berman Group
191
Neuberger Berman Group
New York
– -$277K -9,302 Closed
CAM
192
Cortina Asset Management
Wisconsin
– -$245K -8,220 Closed
FNYS
193
First New York Securities
New York
– -$119K -4,000 Closed
WA
194
Waverly Advisors
Alabama
– -$112K -3,750 Closed
BNP Paribas Financial Markets
195
BNP Paribas Financial Markets
France
– -$88.7K -2,970 Closed
CSS
196
Cubist Systematic Strategies
Connecticut
– -$39K -1,300 Closed
Ameriprise
197
Ameriprise
Minnesota
– -$36K -1,207 Closed
SFM
198
Sphera Funds Management
Israel
– -$30K -1,000 Closed
4 5 6 7
8

AUXL Hedge Fund Activity: Q4 2014 in Review

158 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q4 2014, worth a combined $2.19B — up 11% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new AUXL positions and 40 closed out — a net gain of 10 holders — while 37 added to existing stakes and 53 trimmed.

The largest buyer was Pentwater Capital Management, adding an estimated $121M. The largest seller was Fidelity Investments, exiting entirely with an estimated $190M sold.

  • 158 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q4 2014, up from 150 in Q3 2014.
  • Funds reported $2.19B of AUXILIUM PHARAMCEUTICALS INC stock for Q4 2014, up 11% quarter-over-quarter.
  • 50 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q4 2014 and 40 closed out, a net change of +10 holders.
  • The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q4 2014 was Pentwater Capital Management, an estimated $121M added.
  • The largest AUXILIUM PHARAMCEUTICALS INC seller in Q4 2014 was Fidelity Investments, an estimated $190M sold.

Based on aggregated 13F filings for Q4 2014.